IL13RA2 and melanoma: Importantly, enhanced IFNγ production and improved target cell killing by PD-1high CAR T cells was observed in human anti-IL-13 receptor α2 (IL13Rα2) CAR-T cells co-incubated with a human melanoma cell (Supplementary Figure 4).